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Abstract
Approximately 2 billion people currently suffer from intestinal helminth infections, which are typically chronic in nature and
result in growth retardation, vitamin A deficiency, anemia and poor cognitive function. Such chronicity results from co-
evolution between helminths and their mammalian hosts; however, the molecular mechanisms by which these organisms
avert immune rejection are not clear. We have found that the natural murine helminth, Heligmosomoides polygyrus bakeri
(Hp) elicits the secretion of IL-1b in vivo and in vitro and that this cytokine is critical for shaping a mucosal environment
suited to helminth chronicity. Indeed in mice deficient for IL-1b (IL-1b2/2), or treated with the soluble IL-1bR antagonist,
Anakinra, helminth infection results in enhanced type 2 immunity and accelerated parasite expulsion. IL-1b acts to decrease
production of IL-25 and IL-33 at early time points following infection and parasite rejection was determined to require IL-25.
Taken together, these data indicate that Hp promotes the release of host-derived IL-1b that suppresses the release of innate
cytokines, resulting in suboptimal type 2 immunity and allowing pathogen chronicity.
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Introduction
Soil-transmitted helminths (STH) are parasitic nematodes that
currently infect billions of people worldwide [1]. They can live for
many years as adult worms within the human gastrointestinal
tract, with the heaviest worm burdens found in preschool and
school-age children living in impoverished communities [2].
Heligmosomoides polygyrus bakeri (Hp) is a widely used murine STH
that mimics the life-cycle and chronicity of many human
helminths. It is a natural parasite of mice that enters the gastro-
intestinal tract as third-stage infective larvae (L3), then penetrates
the epithelial cell barrier of the small intestine to mature within the
submucosa to an L4 stage, during which period it elicits a type 2
dominated inflammatory response [3,4]. The parasite eventually
exits the intestinal mucosa to populate the intestinal lumen where
it establishes a chronic infection as a sexually mature adult [5].
Although the mechanisms by which Hp establishes chronicity in its
host remain unclear, it is well established that this helminth
possesses potent immunomodulatory properties. Indeed Hp has
been reported to ameloriate various inflammatory diseases in-
cluding allergic asthma [6,7] and inflammatory bowel disease
[7,8], to directly modulate dendritic cell (DC) function [9] and to
promote de novo Foxp3 expression by splenocytes in vitro [10].
Protective immunity is thought to be mediated largely against the
tissue invasive L4 stage [11,12], and immune damage inflicted on
the parasite during this stage can lead to a halt in the life cycle
[11,12] or the emergence of damaged worms that are more easily
expelled from the intestinal lumen [13].
The IL-1 cytokine family comprises 11 members, including IL-
1b. Production of active IL-1b is a tightly controlled process. Pro-
inflammatory stimuli can activate the expression of the proform of
IL-1b, while maturation is regulated by inflammasome formation.
Inflammasomes, such as the Nlrp3 and Nlrp6 inflammasomes, are
molecular platforms comprised of a NOD-like receptor (NLR)
family protein, the adaptor protein apoptosis-associated speck-like
protein containing a caspase recruitment domain (ASC) and pro-
caspase-1. Upon stimulation these proteins oligomerize and enable
auto-activation of caspase-1 (Casp1), which can then mediate
cleavage, and activation, of IL-1b [14]. Among the inflamma-
somes described to date, the Nlrp3 inflammasome is the best
characterized. The Nlrp3 inflammasome is known to be activated
by a wide range of stimuli such as asbestos, silica, monosodium
urate crystals (MSU), adenosine triphosphate (ATP) and ultraviolet
B (UVB) irradiation [15,16]. So far IL-1b production has been
linked to several pathological diseases including rheumathoid
arthitis [17], gout [18] and type 2 diabetes [19], and it was shown
that treatment with Anakinra, an IL-1b receptor antagonist,
improved disease outcomes [20,21,22]. IL-1b is also upregulated
in the intestines of patients suffering from inflammatory bowel
disease [23,24,25,26]. Pathogens can elicit IL-1b secretion and it is
necessary for the effective clearance of Salmonella typhimurium
(Nlrp3 and Nlrc4 inflammasomes) [27], Shigella flexneri (Nlrc4
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inflammasome) [28], and Legionella pneumophila [29]. Lastly, a recent
publication indicated that eggs from the cestode helminth,
Schistosoma mansoni, can elicit IL-1b secretion in an Nlrp3
inflammasome-dependent manner [30].
In the current report we uncover a novel role for IL-1b
production in promoting the chronicity of intestinal helminth
infection. Hp infection elicited a strong early production of IL-1b,
which was determined to favour the development of parasite
chronicity through its ability to suppress helminth-induced IL-25,
resulting in attenuated type 2 immunity. These findings uncover
one of the means by which Hp establishes a chronic infection
within its murine host, and represents the first evidence of
a negative role for IL-1b in protective immunity following
pathogen infection.
Results
Hp parasites and their excretory/secretory products
activate the Nlrp3 inflammasome to elicit IL-1b release
We analyzed factors induced early after infection of WT
(C57BL/6) mice with Hp and observed a significant increase in
IL-1b cytokine levels in the peritoneal wash (Fig. 1A), a site
previously shown to contain inflammatory cells following Hp
infection [31]. IL-1b was also elevated in the intestine (Fig. 1B)
with a peak at 3–6 days post infection (dpi). Here, IL-1b
production was most prominent in the duodenum, and to a lesser
extent within the jejunum, correlating with the sites of heaviest
worm burdens (Fig. 1C). We next generated bone marrow (BM)
chimeras using WT and IL-1b2/2 mice to identify the cellular
compartment responsible for IL-1b secretion. Fig. 1D shows
similar increases in IL-1b cytokine levels from duodenum tissue
cultures at 6 dpi in IL-1b2/2 recipient mice reconstituted with
WT BM cells (IL-1b2/2/WT) and WT (WT/WT) controls, whilst
very little IL-1b was detected in WT recipients reconstituted with
IL-1b2/2 BM cells. Western blot analysis of hematopoietic cells
isolated from the intestinal lamina propria tissue layer of Hp
infected WT mice at 6 dpi demonstrated that both CD11b+ and
CD11b2 cells can express IL-1b, indicating that multiple cells
types are likely to contribute to production of this cytokine
(Fig. 1E). However, predominantly more IL-1b expression on
a per-cell-basis was noted within the CD11b+ compartment,
indicating that CD11b+ macrophages may be a particularly rich
source of this cytokine following helminth infection (Fig. 1E).
IL-1b plays a key role during many inflammatory responses
[32]. Inflammatory stimuli can induce expression of proIL-1b
through NFkB activation, but this requires cleavage and release of
the mature form to be active. Cleavage of proIL-1b can occur via
inflammasome activation of caspase-1. To determine whether Hp
could induce expression of proIL-1b we stimulated WT, Trif2/2
and MyD882/2 BM derived macrophages (BMM) with whole
extracts from L5 Hp worms (HPL5), L5 Hp excretory secretory
proteins (HES)(which contains low levels of contaminating LPS) or
pyrogen-free HES (P.HES). We then examined proIL-1b expres-
sion by Western blot. WT BMMs showed strong expression of
proIL-1b following stimulation with HPL5, HES or P.HES after
4 hours (Fig. 1F). Trif2/2 and, even more dramatically MyD882/2
BMMs, showed reduced levels of proIL-1b following HPL5, HES
or P.HES stimulation (Fig. 1F), demonstrating that Hp products can
activate NFkB pathways dependent on both Trif and MyD88. Next,
to determine whether Hp products could activate inflammasome
activity and mature IL-1b secretion we stimulated WT, Asc2/2 or
Nlrp32/2 BMMs with HPL5, P.HES or LPS plus MSU (as
a positive control). After 18 hours IL-1b expression was detected by
Western blot and ELISA. As expected LPS plus MSU treatment
induced inflammasome activation in WT BMMs, which was absent
in Asc2/2 and Nlrp32/2 BMMs (Fig. 1G). WT, Asc2/2 and
Nlrp32/2 BMMs all showed expression of proIL-1b following
stimulation with the Hp products, demonstrating that the cells are
equally viable and that proIL-1b expression is not dependent on Asc
or Nlrp3 (Fig. 1G). WT, but not Asc2/2 or Nlrp32/2, BMMs
demonstrated cleavage and secretion of IL-1b (Fig. 1G), indicating
that Hp products can activate the NLRP3 inflammasome. Similar
results were obtained using THP-1 cells with knock-down (kd) for
ASC or NLRP3. THP-1 cells with mock shRNA treatment released
IL-1b when stimulated with HPL5, HES or P.HES, whilst ASCkd
or NLRP3kd THP-1 cells did not (Fig. S1). No differences in IL-1b
release were detected for BMM or THP-1 cells stimulated with HES
or P.HES, suggesting that contaminating LPS did not contribute to
IL-1b secretion, but that it resulted from direct stimulation by
helminth-derived products. Taken together, these data indicate that
Hp products can stimulate IL-1b secretion by hematopoietic cells
through a pathway involving the Nlrp3 inflammasome.
IL-1b promotes chronic Hp infection in mice
We next investigated the functional role of IL-1b production
during Hp infection. IL-1b2/2 mice infected with Hp demon-
strated similar worm burdens at early timepoints when mature L5
Hp first enter the intestinal lumen (Fig. 2A). However, whilst the
bulk of worms in WT mice were located in the duodenum, IL-
1b2/2 mice harbored increased numbers of worms in both the
duodenum and jejunum (Fig. 2A). Location of adult worms further
along the small intestine is typically associated with immune
damage leading to impaired worm health, fecundity and more
rapid expulsion [33]. In keeping with this, a strong reduction in
Hp worms was noted along the entire small intestine of IL-1b2/2
mice at a late timepoint post-infection (day 40) (Fig. 2B). In
addition, IL-1b2/2 mice exhibited reduced egg output over the
entire timecourse of the experiment (Fig. 2C). Type 2 granulomas
form around the invading larvae and resolve slowly after the larvae
Author Summary
Parasitic soil-transmitted helminths (STH) live, feed and
mate within the intestine of their mammalian hosts.
Infection is caused by ingestion of eggs and larvae or by
active penetration of the skin by larvae from contaminated
soil in poverty stricken areas lacking adequate sanitation.
Infection with soil-transmitted helminths results in a wide
range of symptoms including intestinal complications
(diarrhea, abdominal pain), anemia, general malaise and
nutritional deficiencies that negatively impact on working
and learning capacities and impair physical growth. The
host typically raises a strong type 2 immune response
against the invading helminth; however, the majority of
helminthes have developed the capacity to escape
effective immunity and can remain chronically within the
intestine for years. We explored the mechanisms re-
sponsible for helminth chronicity using a murine model
of Heligmosomoides polygyrus bakeri (Hp) infection. We
found that Hp is able to induce IL-1b secretion in the
intestine and that this cytokine acts to suppress the
production of the innate cytokines IL-25 and IL-33.
Furthermore, we show that parasite rejection requires IL-
25 indicating that suboptimal production of this cytokine
in the presence of IL-1b is responsible for the ability of IL-
1b to promote parasite chronicity. Our study provides new
insights into the mechanisms used by helminths to
establish chronic infections, and reveals a novel role for
IL-1b in protective immunity.
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Figure 1. Hp infection elicits IL-1b secretion. (A–E) Mice were administered 200 L3 Hp by oral gavage. IL-1b protein levels were measured by
ELISA in (A) the peritoneal wash and (B) intestinal tissue culture supernatants at the indicated timepoints. (C) Hp worm counts were performed for
defined segments of the small intestine from WT (C57BL/6) at 13 dpi. (D) IL-1b was measured by ELISA for duodenum tissue culture supernatants of
day 6 infected bone marrow chimera mice (donor strain/recipient strain). Results are representative of at least 3 independent experiments (n = 5 per
group) and expressed as mean6 SEM. (E) Intestinal lamina propria CD11b+ and CD11b2 cells were isolated at 6 dpi and analyzed by Western blot for
IL-1b expression. Band intensity for IL-1b and b-actin was determined using Adobe Photoshop CS3. The ratio between IL-1b and the control protein
b-actin band intensity was then determined. IL-1b is expressed as percent of b-actin intensity. (F) BMMs from WT (C57BL/6), Trif2/2 or MyD882/2
mice were stimulated in vitro with HPL5 (100 mg/mL), HES (5 mg/mL) or P.HES (5 mg/mL) for 4 hours and cell extracts were analyzed for pro-IL-1b
expression by Western blot. (G) BMMs from WT (C57BL/6), Asc2/2 or Nlrp32/2 mice were stimulated in vitro with P.HES, HPL5 or LPS plus MSU and
culture supernatants (SN) were analyzed for active IL-1b by ELISA. Cell extracts (XT) and SN were also analyzed for pro- or mature- IL-1b by Western
blot. Pro-Casp1 was used as a control protein. XT blots for IL-1b and Casp1 demonstrate the pro-forms, and the observed lower bands in the IL-1b
and Casp1 blots are cleavage products. Error bars represent means of triplicate cultures 6 SEM and the experiment was repeated 3 times.
doi:10.1371/journal.ppat.1003531.g001
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Figure 2. IL-1b promotes chronicity of Hp infection in mice. Mice were administered 200 L3 Hp by oral gavage (A–M). The number of adult
worms were determined for the entire and defined segments, of the small intestine of WT (C57BL/6) and IL-1b2/2 mice at (A) 13 dpi and (B) 40 dpi.
(C) Fecal egg counts were determined for WT (C57BL/6) and IL-1b2/2mice throughout the course of the experiment (data represents pooled feces of
2–3 individual cages per strain, n = 2–5 mice per cage). Numbers of type 2 granulomas were determined for the entire and defined segments of the
small intestine of WT (C57BL/6) and IL-1b2/2 mice at (D) 13 dpi and (E) 40 dpi. IL-1a (F) and IL-1ra (G) protein levels were measured by ELISA in
duodenum tissue culture supernatants at the indicated timepoints after Hp infection. (H–I) WT (C57BL/6) mice were administered 200 L3 Hp by oral
gavage and additionally received 100 ml of PBS (WT) or PBS plus 50 mg/kg Anakinra (WT+Anakinra) via i.p. injection every day from 0–10 dpi. The
number of (H) adult Hp worms and (I) type 2 granulomas were determined for the entire and defined segments of the small intestine at 10 dpi. (J)
Fecal egg counts were determined at 10 dpi (data represents pooled feces from 1 cage per strain, n = 5 mice per cage). (K–L) WT (C57BL/6) mice were
administered 200 L3 Hp larvae by oral gavage and additionally received 100 ml of PBS (WT) or PBS plus 50 mg/kg Anakinra (WT+Anakinra (10 d)) via
i.p. injection every day from 0–10 dpi. Mice were sacrificed at day 36 dpi and the number of (K) adult worms and (L) type 2 granulomas determined
for the entire and defined segments of the small intestine. (M) Number of adult worms were determined for the entire and defined segments of the
small intestine of WT (C57BL/6) and IL-1R12/2 mice at 13 dpi. All data are representative of 3 independent experiments (n = 5–10 per group) and
expressed as mean 6 SEM.
doi:10.1371/journal.ppat.1003531.g002
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emerge as adults into the intestine. Thus large numbers of
granulomas are typically seen within the first few weeks post-
infection and decrease thereafter. IL-1b2/2 mice exhibited
increased numbers of intestinal granulomas at both early and late
timepoints following infection (Figs. 2D–E). We also observed an
increased proportion of granulomas in the jejunum of IL-1b2/2
mice suggesting that Hp larvae are forced to invade the intestine at
a more distal location (Fig. 2D). These data may indicate a very
early increase in immune responsiveness in the absence of IL-1b.
To ensure that the observed phenotype resulted from the absence
of IL-1b, and not alterations to other components of the IL-1
signaling pathway, we measured IL-1a and IL-1ra cytokine levels
in the intestinal duodenal tissue cultures of WT and IL-1b2/2
mice. These analyses showed that Hp infection increases both IL-
1a and IL-1ra, however no significant differences were observed
between WT and IL-1b2/2 mice (Figs. 2F–G).
Anakinra treatment mimics the phenotype of IL-1b2/2
mice following Hp infection
To exclude any intrinsic defects in genetically targeted IL-1b2/2
mice, we also blocked IL-1b activity pharmacologically by treating
WT (C57BL/6) mice daily with Anakinra. Similar to the results
observed in IL-1b2/2 mice, Anakinra-treated WT mice did not
show any difference in total worm burdens in the complete small
intestine at early timepoints following infection, however an
increased number of worms were located towards the posterior
end of the small intestine indicating reduced parasite fitness
(Fig. 2H). Anakinra treated mice also exhibited increased numbers
of granulomas (Fig. 2I) and reduced egg outputs (Fig. 2J). In keeping
with published data that immune damage to tissue- invasive larvae
during the early phase of the immune response correlates with
greater expulsion of adult worms, we could show that limiting
Anakinra treatment to the first 10 days of infection was sufficient to
decrease worm burdens (Fig. 2K) and increase granuloma numbers
(Fig. 2L) during the chronic phase of infection (day 36 post-
infection). IL-1R12/2 also exhibited reduced worm burdens as
compared to WT mice (Fig. 2M). Taken together, these data show
that IL-1b normally acts to promote Hp chronicity.
IL-1b attenuates Th2 cell immunity following Hp
infection
Protective immunity following challenge with Hp infection is
known to require CD4+ T cells [34] and worm expulsion during
primary infection is defective in SCID mice [35]. Moreover, IL-4
complex treatment can reduce worm numbers and fecundity in
established Hp infection [35]. To determine whether IL-1b
modulated Th2-type immunity we analyzed the peak CD4+ T
cell response in IL-1b2/2 and WT mice following Hp infection.
IL-1b2/2 mice showed a significantly increased percentage of IL-
4 and IL-13 positive CD4+ T cells following in vitro restimulation of
splenic or MLN cells with HES (Fig. 3A–D). By contrast no
differences were found in the percentage of CD4+ cells secreting
IFN-c in response to HES stimulation (Figs. 3E–F). Cultures using
cells from Hp infected mice cultured without HES, or cells from
naive control mice cultured with HES, showed minimal numbers
of cytokine positive cells (data not shown). Hp infection was not
observed to result in the differentiation of IL-17 producing CD4+
cells in WT mice (Figs. S2A–B), nor could we detect HES-induced
IL-17 production in the supernatants of cells obtained from Hp
infected WT or IL-1b2/2 mice (data not shown). There were also
no differences in the numbers of CD25+Foxp3+ Treg cells present
in the MLN or spleen of infected WT versus IL-1b2/2 mice
(Figs. S2C–D). In support of the increased Th2 immunity observed
in IL-1b2/2 mice we also detected increased total serum IL-4
(Fig. 3G), serum IgE (Fig. 3H) and HES-specific IgG2b (Fig. 3I).
Total IgG levels, which increase independently of IL-4 [12], didn’t
differ between WT and IL-1b2/2 mice (Fig. 3J). Only minimal
increases in IgG1 were seen at this timepoint (Fig. 3K) and no
HES-specific IgG2a could be detected (data not shown).
IL-1b secretion negatively regulates Hp-induced IL-25
and IL-33 cytokine production
The cytokines IL-25 and IL-33 (a member of the IL-1 family)
have been shown to play a crucial role in the regulation of type 2
cytokine production [36,37,38], to be produced rapidly following
helminth infection, and to promote protective immunity against
Trichuris muris [39], Nippostrongylus brasilienis [40] and Hp [41]. We
therefore analyzed the impact of IL-1b on IL-25 and IL-33
production following Hp infection. Hp elicited the production of
both IL-25 and IL-33, and this production was greatly enhanced
in the absence of IL-1b (Figs. 4A–F). Increased IL-25 and IL-33
production in the absence of IL-1b could be detected in both the
peritoneal wash (Figs. 4A–B) and intestinal duodenal tissue
cultures (Figs. 4C–D). Anakinra treatment of WT mice also
resulted in increased production of these cytokines, supporting our
findings in IL-1b2/2 mice (Figs. S3A–B). In the intestine, Hp
infection increased IL-25 and IL-33 mRNA expression was most
predominant in isolated intestinal epithelial cells (IEC) (Figs. 4E–
F), whilst it could not be detected in the lamina propria (data not
shown). To determine the possible targets of IL-1b, we stained
intestinal sections for expression of the IL-1R1. IL-1R1 was
observed to be scattered throughout the intestine, and was
particularly prodominant on IEC cells, although expression levels
did not alter following infection (Fig. 4G). We therefore de-
termined whether IL-1b could act directly on IECs to limit IL-25
and/or IL-33 production by stimulating IECs from the mouse
small intestine (MSIE cells) [42] with HES in the presence or
absence of rIL-1b. HES elicited the production of IL-33 mRNA
by MSIE cells and this was attenuated by addition of rIL-1b
(Fig. 4H). Although IL-25 mRNA could not be detected in these
experiments, Sonobe et al. [43] have reported that IL-1b can down
regulate IL-25 production by brain capillary endothelial cells
indicating cross-talk between these cytokines and stromal cells.
Together, these data indicate that IL-1b acts to negatively regulate
helminth-induced IL-25 and IL-33 production, possibly through
actions on IEC.
We next investigated the contribution of these cytokines to the
expulsion of adult worms from the intestine. Interestingly, mice
lacking IL-25 exhibited elevated worm burdens and fecal egg
counts, whilst animals lacking the IL-33R (T1/ST2) were
comparable to WT controls (Fig. 4I and Fig. S3C). Animals
deficient in both the IL-25 and IL-33 receptors exhibited an
intermediate phenotype indicating that IL-33 may actually
promote worm chronicity. Taken together, these data indicate
that IL-1b acts to suppress the production of Hp-elicited IL-25 and
IL-33 and that the ability of IL-1b to attenuate IL-25 likely
accounts for its impact on parasite chronicity.
IL-1b limits the expansion of innate-like lymphoid cells
(ILC)
IL-25 is a potent stimulator of a novel cell population commonly
referred to as innate lymphoid cell type 2 (ILC2) [44]. These cells
lack markers of known leukocyte lineages, but express c-kit, ICOS,
TI/ST2 (IL-33R) and variable levels of Sca-1 [40,45,46,47]. They
represent a potent early source of IL-13 and IL-5 and promote
goblet cell hyperplasia, eosinophil hematopoesis and adaptive type
IL-1b Maintains Helminth Chronicity
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Figure 3. IL-1b negatively regulates the development of CD4+ Th2 cells following Hp infection.Mice were administered 200 L3 Hp by oral
gavage. At 13 dpi single cell suspensions were made from the (A, C, E) spleen and (B, D, F) MLN, and cells restimulated with HES as described in the
Materials and Methods. The percentage of CD4+ T cells secreting (A, B) IL-4, (C, D) IL-13 and (E, F) IFNc is shown for WT (C57BL/6) or IL-1b2/2 mice.
Serum was taken at 13 dpi and levels of (G) IL-4, (H) total IgE, (I) HES specific IgG2b, (J) total IgG and (K) HES specific IgG1 determined. All results are
representative of 3 independent experiments (n = 5–7 per group) and expressed as mean 6 SEM.
doi:10.1371/journal.ppat.1003531.g003
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Figure 4. IL-1b attenuates Hp-induced IL-25 and IL-33 cytokine production.WT (C57BL/6), WT (Balb/c), IL-1b2/2 (C57BL/6), IL-252/2(Balb/c),
T1ST22/2 (Balb/c) and IL-17Br6T1ST22/2 (Balb/c) mice were administered 200 L3 Hp by oral gavage. (A, C) IL-25 and (B, D) IL-33 cytokine levels were
IL-1b Maintains Helminth Chronicity
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2 responses [40,45,48]. N. brasiliensis infection is a potent inducer of
ILC2 expansion, and although these cells are relatively rare in WT
mice following Hp infection their numbers could be substantially
increased upon additional treatment with exogenous rIL-25 [49].
We investigated the presence of ILC2s following Hp infection of
WT or IL-1b2/2 mice. ILC2s were identified by staining various
tissues for lineage negative (Gr-1, CD3, CD19), sca-1, c-kit, T1/
ST2, ICOS positive cells (Fig. 5A). Hp infection elicited a small
but non-significant increase in ILC2s in the spleen at 6 dpi
(Fig. 5B). Importantly ILC2 expansion was markedly increased in
IL-1b2/2 mice (Fig. 5B), and their identity as ILC2s was
confirmed by an extended lineage negative panel (Fig. S4A) and
by their potential to produce IL-13 (Fig. S4B). The increased ILC2
expansion in IL-1b2/2 mice correlated with increased early IL-5
and IL-13 cytokine production (Figs. 5C–D), helminth-induced
eosinophilia (Fig. 5E) and goblet cell hyperplasia (Fig. 5F). The
stronger increase in ILC2 numbers in the absence of IL-1b
following Hp infection could be confirmed by pharmacological
blockade with Anakinra (Fig. 5G), and Anakinra treated mice
additionally exhibited increased eosinophilia and IL-5 and IL-13
cytokine levels (Figs. S4C–E). To determine whether IL-25 played
a role in promoting Hp-induced ILC2 expansion in the absence of
IL-1b we treated IL-252/2 mice with Anakinra. As expected,
Anakinra treatment of IL-252/2 mice failed to expand ILC2
numbers (Fig. 5G), confirming an important role for this cytokine
in Hp-induced ILC2 expansion.
Increased ILC2 numbers alone are not sufficient for
expulsion of Hp
Absolute ILC2 numbers in Hp infected WT (Balb/c), IL-252/2,
T1ST22/2 and IL-17BR6T1ST22/2 mice (Fig. 6A) showed
a negative correlation to worm burdens (Fig. 4I), indicating
a possible role in worm expulsion as reported for ILC2s in N.
brasiliensis infection [40,45,46,47,48,50,51]. We therefore investi-
gated whether increased ILC2 numbers in the absence of IL-
1b2/2 were sufficient to promote Hp expulsion. RAG2/2 mice,
which harbor ILC2s but lack CD4+ T cells, were treated with
Anakinra following Hp infection resulting in increased duodenal
IL-25 (Fig. 6B), IL-33 (Fig. 6C). These data correlated with
a tendency towards increased splenic ILC2 numbers, although
this did not reach statistical significance (Fig. 6D). However, in
contrast to WT mice (Fig. 2H), Anakinra treatment of RAG2/2
mice failed to impact on total worm numbers or worm location
within the intestinal lumen (Fig. 6E). RAG2/2 mice, either with
or without Anakinra treatment, also failed to generate granulo-
mas in response to Hp larval invasion (data not shown), despite
exhibiting increased IL-5 (Fig. 6F) levels and increased peritoneal
eosinophilia (Fig. 6H). As for ILC2 numbers, IL-13 levels
reproducibly demonstrated a slight increase following Anakinra
treatment, however this did not reach statistical significance
(Fig. 6G). Taken together, these data indicate that early IL-5
production and peritoneal eosinophilia occur independently of T
cells following Hp infection. As ILC2s are known to be present in
RAG2/2 mice [45] our data also indicates that these cells are not
sufficient to promote granuloma formation or parasite expulsion.
However, our data does not rule out a role for ILC2s during Hp
infection of T and B cell competent mice by promoting the
proper expansion and differentiation of Th2 cells.
Discussion
The potential of STH to evade host immunity is an essential
part of their survival strategy. Infection with Hp, a natural parasite
of murine rodents, normally elicits a Th2-type immune response
that nevertheless fails to expel the parasite, resulting in chronic
infection. In the present study we have identified a novel role for
IL-1b in attenuating type 2 immunity and promoting parasite
chronicity (Fig. 7). The role of IL-1b in modulating type 2
immunity has been addressed in prior studies with conflicting
results. Early studies highlighted the requirement for IL-1 in the
development of Th2 cells in vitro [52,53,54], whilst other studies
showed an involvement of IL-1 in promoting IFNc secretion by
Th1 cells [55] and a suppressive effect of IL-1a and IL-1b on IL-4
secretion by human T cells [56]. In vivo, IL-1R1 deficiency was
shown to result in enhanced Th2-type immune responses following
infection with the protozoan parasite Leishmania major [57] and IL-
1a was reported to promote Th1-biased immune resistance to
Leishmania major [58]. In contrast to these findings, both IL-1a2/2
and IL-1b2/2 mice exhibit defective Th2-mediated resistance to
the helminth T. muris [59,60], and IL-1a, IL-1b have been
reported to be necessary for promoting airway inflammation [61]
and particle-induced pulmonary inflammation [62], respectively.
Our data clearly shows a role for IL-1b in attenuating protective
type 2 immunity following Hp infection, however it will be
necessary to study the role of this cytokine in modulating resistance
against other species in order to gain a thorough picture of its
exact role during helminth infection.
Following Hp infection IL-1b was predominately expressed by
hematopoietic cells – most likely intestinal and peritoneal
macrophages. Hp products could induce both the expression of
proIL-1b and inflammasome activation resulting in the cleavage
and maturation of IL-1b, in an Nlrp3 and ASC-dependent
manner. Although IL-1b is normally associated with protective
immunity against pathogens, our data indicate a novel role for this
cytokine in promoting pathogen chronicity. IL-1b gene deficiency,
or the use of the IL-1R1 antagonist Anakinra, resulted in faster
worm expulsion following Hp infection and reduced worm
fecundity. These findings coincided with increased type 2 intestinal
granuloma formation, ILC2 expansion and Th2 cytokine pro-
duction. In turn, this response led to increased helminth-induced
eosinophilia, goblet cell hyperplasia and serum IgE. Interestingly,
restricting IL-1b blockade to the first 10 days of infection also
resulted in a reversal of parasite chronicity indicating that the
strength of the type 2 immune response during the acute phase of
infection can result in parasite damage that impacts on the ability
of the worm to establish chronicity. The early burst of IL-1b
production observed following Hp infection would thus be
expected to be adequate to allow the parasite to escape such
damage and to establish chronicity.
In our study IL-1b was additionally determined to suppress
helminth-induced IL-25 and IL-33. IECs are thought to represent
the major source of early IL-25 and IL-33 following helminth
infection [38,48,63]. In keeping with this, we identified IECs
measured by ELISA in (A–B) peritoneal wash and (C–D) intestinal duodenum tissue culture supernatants from at the indicated timepoints following
Hp infection. mRNA expression for (E) IL-25 and (F) IL-33 in isolated intestinal epithelial cells were determined at 0, 3 and 6 dpi. (G) IL-1R1 expression
was determined for the duodenum in naive and Hp infected WT (C57BL/6) at 6 dpi by immunohistochemistry. Scale bars represent 200 mm, and
50 mm for the inlet. (H) The mouse epithelial cell line (MSIE) was stimulated in vitro with HES (5 mg/ml) with or without additional rIL-1b and measured
for IL-33 mRNA levels by RT-PCR. (I) Adult worm numbers determined for the entire small intestine at 45 dpi. All data are representative of 3
independent experiments (n = 5 per group), and expressed as mean 6 SEM.
doi:10.1371/journal.ppat.1003531.g004
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within the intestinal tissue as a dominant source of IL-25 and IL-
33 production following Hp infection. We believe that IL-1b may
act directly on IECs to attenuate IL-25 production as we and
others have shown that IECs express the IL-1R1 [64,65,66]. We
could also demonstrate IL-1b-mediated inhibition of HES-induced
IL-33 mRNA by murine IEC in vitro. However IL-25 and IL-33
Figure 5. IL-1b attenuates Hp-induced increases in type 2 innate lymphoid cells (ILC2). WT (C57BL/6), WT (Balb/c), IL-1b2/2 and IL-
17Br6T1ST22/2 mice were administered 200 L3 by oral gavage. (A) ILC2 cells were identified as lineage-negative (Gr-1, CD3, CD19), Sca-1, c-kit, T1/
ST2 and ICOS positive live cells present in the spleen of mice at 6 dpi. (B) Absolute numbers of splenic ILC2 cells and levels of (C) IL-5 and (D) IL-13
protein present in the peritoneal wash at 3 and 6 dpi as determined by ELISA. (E) Absolute numbers of eosinophils present in the peritoneal wash at
the indicated timepoints following Hp infection were determined by differential cell counting of cytospins. (F) Intestinal sections were stained with
PAS and the percentage of intestinal epithelial cells represented by PAS+ goblet cells determined. Scale bars represent 200 mm. (G) WT (Balb/c), IL-
252/2 and IL-17BR6T1ST22/2 mice were treated daily with 100 ml of PBS or PBS plus 50 mg/kg Anakinra for 6 consecutive days starting at day 0 of
Hp infection. Absolute numbers of ILC2 cells were determined in the spleen at 6 dpi. All data are representative of at least 2 independent experiments
(n = 5–10 per group) and expressed as mean 6 SEM.
doi:10.1371/journal.ppat.1003531.g005
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can also be produced by other cell types, such as macrophages and
mast cells [41,67], and it is possible that IL-1b additionally
modulates cytokine levels by acting on these cells. Determination
of the exact molecular mechanisms by which IL-1b can
attenuate IL-25 and IL-33 expression will be important for future
studies.
IL-25 and IL-33 have recently been identified as potent
inducers of type 2 immunity through their actions on ILC2
[47,48] and CD4+ T cells [37,68]. We noted that IL-25 and IL-
33 production in WT mice was relatively poor following Hp
infection, perhaps explaining why this parasite establishes
chronicity, whilst N. brasiliensis, which elicits a strong IL-25 and
IL-33 response [46,63,69], does not. Hepworth et al., [49] also
reported negligible increases in ILC2 numbers in WT mice after
Hp infection and we could reproduce these data. Interestingly,
IL-1b2/2 mice exhibited increased ILC2 numbers, a finding
likely explained by the impact of IL-1b on IL-25 as Hepworth et
al., [49] could show that rIL-25 treatment of Hp infected mice
expanded ILC2s, and we showed that ILC2 expansion following
Anakinra treatment was IL-25 dependent. IL-25 deficient mice
exhibited increased worm burdens at late time-points post-
infection, indicating that even in the presence of normal IL-1b
signaling low levels of IL-25 have a critical role in mediating
worm expulsion. Thus we speculate that the main function of IL-
1b is to suppress exaggerated IL-25-induced immune responses
that give rise to almost complete worm expulsion. This hypothesis
is supported by a recent study showing that treatment of Hp
infected WT mice with rIL-25 results in the acute expulsion of
adult worm burdens [41].
Although we observed that IL-25 was required for Hp-induced
ILC2 expansion, RAG2/2 mice which retain ILC2s but lack
CD4+ T cells, did not form granulomas and failed to expel
parasites following Hp infection. These data indicate that Th2 cells
are required for parasite expulsion. Previous studies indicate that
ILC2s can act to promote tissue eosinophilia, goblet cell
hyperplasia and expansion of Th2 cells [40,45,46,47,50]. IL-25
can also act on a number of cell types to promote type 2 immunity
including ILC2s [47], antigen-presenting cells [70], invariant
NKT cells [71], mast cells [72] and Th2 cells [37,73]. Thus,
increased IL-25 production in the absence of IL-1b may act to
promote Hp expulsion by Th2 cells in a direct manner, or
indirectly through its effects on other cell subsets.
In conclusion, our data reveals a novel role for IL-1b in
promoting helminth chronicity. The means by which IL-1b
achieves this includes, but may not be limited to, i) suppression of
helminth-elicited IL-25 and IL-33 secretion, ii) diminished ILC2
numbers and iii) attenuated Th2-type immune responses (Fig. 7).
This course of events allows Hp to escape Th2-dependent immune
damage and to establish a chronic infection. Of note, IL-25 and IL-
33 have been reported to modulate the severity of various
inflammatory diseases involving IL-1b secretion including allergic
inflammation, autoimmunity and inflammatory bowel disease
[74,75]. Thus, our findings are likely to have important implications
for numerous diseases in addition to helminth infection.
Figure 6. ILC2s alone are not sufficient enough to reject Hp worms and function mainly to support Th2 responses.WT (Balb/c), RAG2/2,
IL-252/2, T1ST22/2 and IL-17Br6T1ST22/2mice were administered 200 L3 Hp by oral gavage. (A) ILC2 numbers in WT (Balb/c), IL-252/2, T1ST22/2 and
IL-17Br6T1ST22/2 mice were determined in the spleen at 6 dpi. Hp infected RAG2/2 mice additionally received 100 ml of PBS (RAG2/2) or PBS plus
50 mg/kg Anakinra (RAG2/2+Anakinra) via i.p. injection every day until 6 dpi to analyze, (B) IL-25 and (C) IL-33 cytokine levels in intestinal duodenum
tissue cultures. (D) Absolute splenic ILC2 numbers. (E) Hp infected RAG2/2 mice additionally received 100 ml of PBS or PBS plus 50 mg/kg Anakinra via
i.p. injection from 0–10 dpi and total worm numbers were analyzed at 13 dpi. (F) IL-5 and (G) IL-13 protein present in the peritoneal wash at 6 dpi as
determined by ELISA. (H) Absolute numbers of eosinophils present in the peritoneal wash at 6 dpi were determined by differential cell counting of
cytospins. All data are representative 3 independent experiments (n=5–10 per group) and expressed as mean 6 SEM.
doi:10.1371/journal.ppat.1003531.g006
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Materials and Methods
Ethics statement
All animal experiments were approved by the office Affaires
ve´te´rinaires (1066 Epalinges, Canton Vaud, Switzerland) with the
authorization Number 2238 according to the guidelines set by the
Service de la consommation et des affaires ve´te´rinaires federal
(Canton Vaud, Switzerland).
Mice, parasites and treatments
C57BL/6, Balb/c, Asc2/2 [76], Nlrp32/2 [76], Trif2/2 [77],
MyD882/2 [78], IL-1b2/2 [79], IL-1R12/2 [80], RAG-12/2
[81], IL-252/2 [47], T1/ST22/2 [82] and IL-17BR6T1ST22/2
[45] mice were bred and maintained under specific pathogen-free
(SPF) conditions at Ecole Polytechnique Fe´de´rale de Lausanne
(EPFL) or Centre Hospitalier Universitaire Vaudois (CHUV) at
Epalinges, Switzerland. To standardize the intestinal bacteria
within different groups of mice contained within one experiment,
all mice were co-housed or beddings were mixed for 2–3 weeks
prior to parasite infection. Where indicated mice were then
infected orally with 200 L3 Hp. For pharmacological blockade of
IL-1b, mice were additionally treated with 0.1 ml PBS or 50 mg/
kg Anakinra in 0.1 ml PBS via i.p injection once daily, starting on
day 0 of the infection. Adult worm burdens and granuloma
numbers were determined by manual counting using a dissecting
microscope. Egg production was quantified by collection of moist
feces, flotation using saturated NaCl, and counting using
a McMaster Worm Egg Counting Chamber (Weber Scientific
International, Ltd, Hamilton, NJ, USA).
Generation and collection of HES products
For the generation of Hp excretory/secretory (HES) products,
L5 Hp helminths were washed extensively in sterile PBS
supplemented with penicillin and streptomycin (Gibco), then
incubated for 1 h in RPMI (Gibco) supplemented with penicillin
and streptomycin and cultured in RPMI plus antibiotics (penicil-
lin, streptomycin, and gentamicin; Sigma–Aldrich) and 1%
glucose (Sigma–Aldrich). The supernatant was collected every 2
days for a period of 2 weeks, followed by sterile filtration and
concentration of the supernatant by centrifugation through
a 10,000 MWCO cellulose membrane (Centriprep; Millipore).
LPS contamination was removed from HES using an EndoTrap
Blue LPS-binding affinity column (Hyglos GmbH, Germany). The
concentration of residual endotoxin was determined using the
Limulus Assay, which has a sensitivity of 0.06 Endotoxin Units/ml
(6 pg/ml) (Lonza). The final preparation used for this study
contained 31 pg/ml LPS in the pyrogen-free HES (P.HES) vs.
643 pg/ml in the non-purified HES (HES).
Figure 7. Hp induced IL-1b production promotes helminth chronicity. (A) Parasites induce IL-1b secretion by lamina propria (LP) cells. (B) IL-
1b inhibits parasite induced IL-25 and IL-33 secretion by intestinal tissue cells and intestinal epithelial cells (IECs). (C) IL-25 secretion induce innate
lymphoid cells type 2 (ILC2s). (D) ILC2s in combination with IL-25 promote type 2 cytokine production. (E) Type 2 immunity, including goblet cell
hyperplasia and smooth muscle contraction result in expulsion of the adult Hp worms.
doi:10.1371/journal.ppat.1003531.g007
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Bone marrow chimeras
For the generation of bone marrow (BM) chimeras, C57BL/6
and IL-1b2/2 mice were lethally irradiated (9.5 Gy) using a 60
Cobalt source then injected intravenously with 56105 BM cells
depleted of CD4+ T cells by MACs separation. BM chimera mice
were then treated with Biafine cre`me for 3 days and with Bactrim
(60 mg/kg/day) and Paracetamol (200 mg/kg) for 14 days in the
drinking water. 21 days after BM transfer mice were infected with
Hp.
Mononuclear cell isolation from intestinal lamina propria
tissues
Small intestinal lamina propria cells were isolated as previously
described [83]. Briefly, the colon was flushed, opened longitudi-
nally, washed thoroughly in Mg2Cl2- and CaCl2-free DPBS
(GIBCO, Invitrogen, Gaithersburg, MD). The tissues were then
cut into 3–5 mm pieces that were incubated 4–5 times in 25 ml
EDTA/HEPES/DPBS solution at 37uC for 20 min in a shaking
incubator in order to remove the epithelial layer. Intestinal pieces
were collagenase-digested for 40 min at 37uC in 25 ml IMDM
containing 0.5 mg/ml collagenase type VIII (Sigma-Aldrich,
Taufkirchen, Germany), 50 U DNaseI (Roche Diagnostic, Nutley,
NJ), and 0.01 M HEPES (GIBCO, Invitrogen). The crude cell
suspension was loaded onto a 30%/100% percoll (GE Healthcare,
Milan, Italy) gradient and centrifuged at 680 g for 30 min at room
temperature with the acceleration and brake turned off. Cells were
collected from the 30%/100% interphase and further used for
CD11b positive cell isolation using MACS cell separation
technique (Miltenyi Biotech) according to the manufacturer’s
instructions.
Identification of helminth-induced type 2 CD4+ T cells
and ILC2s
Hp induced cytokine production by T cells was assessed by
culturing cell suspensions from the mesenteric lymph node (MLN)
or spleen 72 h in the presence of 5 mg/mL HES at 37uC. At the
end of this period cells were additionally stimulated 4 h with PMA
and ionomycin, with brefeldin A added for the last 2 h of culture.
Cells were then harvested and stained for surface markers, then
fixed with 2% paraformaldehyde before staining with anti-
cytokine antibodies. Antibodies against mouse CD3, CD4,
CD11b, CD11c, CD19, Nk1.1, CD19, CD45, CD127, GR-1, c-
kit, IL-4, IL-7Ra and IgE were from BioLegend; IL-13, Sca-1
from eBioscience and T1/ST2 from Mdbioproducts. For de-
tection of ILC2s spleen cell suspensions were stained with
biotinylated CD3, CD4, CD11b, CD11c, CD19, Nk1.1, Gr-1
and IgE or CD3, CD19 and Gr-1, followed by streptavidin labeled
Texas Red, Sca-1 (PE-Cy7), c-kit (Pacific Blue), T1/ST2 (FITC),
and ICOS (PerCP/Cy5.5) and subjected to a gating strategy as
shown in Figure 7A. All flow cytometry analyses were performed
on a LSRII (BD) and analyzed using FlowJo software (TreeStar).
Peritoneal wash and intestinal tissue culture
Peritoneal washes were performed with 0.5 ml cold PBS using
2–3 washes. For intestinal tissue culture the intestine was removed,
extensively flushed with cold PBS, divided into duodenum,
jejunum and ileum, cut longitudinally and placed separately in
100 mm Petri dishes with PBS containing 10 mg/ml Gentamicin,
100 U/ml Penicillin and 100 mg/ml Streptomycin (all from
GIBCO). Opened cut intestines were gently scraped to remove
mucus, washed 3 times and transferred into a new Petri dish. From
each part of the intestine (duodenum, jejunum and ileum) the
anterior 4 cm were cut into 1–2 mm pieces and transferred to a 24-
well plate with 2 ml/well of RPMI media (PAA Laboratories)
containing 10% heat inactivated FCS, 10 mg/ml Gentamicin,
100 U/ml Penicillin and 100 mg/ml Streptomycin (all from
GIBCO). 24-well plates were incubated over night at 37uC before
supernatants were harvested and analyzed by ELISA. Cytokine
concentrations were normalized against tissue weight and are
presented as pg/mg tissue.
ELISA and Milliplex
Serum samples were analyzed by mouse Milliplex Kit (Merk
Millipore) for IL-4. Peritoneal wash or intestinal tissue culture
supernatants were analyzed by mouse ELISA for IL-1b, IL-5, IL-
33 (eBiosciences) or IL-25 (BioLegend) according to the manu-
facturer’s instructions. ELISA assays for total IgE and IgG were
performed as previously described [12]. Antigen-specific IgG1,
IgG2a and IgG2b were measured in a similar manner after
coating with 1–5 mg/ml HES excretory/secretary products
collected from adult L5 Hp cultured for a period of 2 days in
RPMI plus antibiotics and 1% glucose and concentrated using
a 10,000 MWCO cellulose membrane, Centriprep, Millipore,
MA). To calculate concentrations an internal standard consisting
of pooled serum from C57BL/6 or mice infected two times with
Hp was used.
Real-Time PCR
Tissues were stored in RnaLater (Ambion) or directly trans-
ferred to TRIzol (Invitrogen). RNA was extracted according to the
manufacturer’s instructions. Gene expression results are expressed
as arbitrary units relative to expression of the house keeping gene
b-actin. Primer sequences are as follows: IL-25 (59-CAG CAA
AGA GCA AGA ACC-39 and 59-CCC TGT CCA ACT CAT
AGC-39), IL-33 (59- CAATCAGGCGACGGTGTGGATGG-39
and 59- TCCGGAGGCGAGACGTCACC-39) and ß-actin (59-
CTT TTC ACG GTT GGC CTT AG-39 and 59-CCC TGA
AGT ACC CCA TTG AAC-39).
In vitro inflammasome assay and Western blot
Murine bone marrow derived macrophages (BMM) were
isolated and cultured as previously described [84,85]. The day
before stimulation, cells were collected and plated into flat-
bottom 96-well tissue culture plates at 0.26106 cells per well.
Where indicated, cells were primed with 20 ng/mL ultrapure
E.coli K12 LPS (Invivogen) for 3 hrs followed by MSU (300 mg/
mL) for an inflammasome positive control. Stimulation with HES
(5 or 50 mg/mL), pyrogen-free HES (P.HES) (5 or 50 mg/mL),
homogenized H. polygyrus L5 parasite (HPL5) (100 mg/mL) were
performed for the indicated times. Cell supernatants were
removed and kept for ELISA or Western blot. The cell pellet
was washed with PBS then re-suspended directly in SDS sample
buffer. For Western blot analysis of cell extracts, triplicate
samples were pooled, incubated at 95uC for 5 minutes then
separated on 15% SDS-page gels, transferred onto nitrocellulose
membranes and blotted with polyclonal antibodies against mouse
IL-1b (sheep) and caspase-1 (rabbit) which were generous gifts
from R. Solari (Glaxo) and P. Vandenabeele (Ghent University,
Belgium), respectively. Band intensity for IL-1b and b-actin was
determined using Adobe Photoshop CS3. For band intensity
normalization graph of IL-1b in CD11b+ lamina propria cells,
each sample is normalized to naı¨ve CD11b2, set as 1, for both
IL-1b and b-actin. The ratio between IL-1b and b-actin band
intensity was then determined. IL-1b is expressed as percent of b-
actin intensity.
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Isolation of IECs
IECs were isolated as described previously [63]. Intestines
were cut into 2–3 mm fragments and washed by PBS five times
with vigorous shaking before incubation with 3 mM EDTA and
0.5 mM dithiothreitol at room temperature for 30 min with
shaking. Epithelial cells released from the intestine by shaking
were washed with PBS and transferred into TRIzol. To test for
contamination of leukocytes, washed epithelial cell suspen-
sions were digested by collagenase IV, and single cells were
stained by CD45 antibodies. Only 3.01%60.45 in WT and
3.27%60.57 in IL-1b2/2 of the acquired cells were stained
positive for CD45.
MSIE culture
MSIE cell line [42] cells were expanded at 33uC with 5% CO2
in the presence of IFNc. Cells were further differentiated for 2
days at 37uC without IFNc after which they were stimulated for
2 h (for RNA extraction) or 24 h (for supernatant collection and
protein analysis) with papain (Calbiochem) or HES (L5 Hp
excretory secretory products) alone, or in combination with
different concentrations of rIL-1b (R&D systems).
Histology and goblet cell measurements
4 mm paraffin sections of swiss rolls from different sections of the
small intestine were stained with PAS for evaluation of goblet cells.
Goblet cell hyperplasia was determined by counting the number of
PAS positive cells in 10 villi per section. The results were expressed
as percentages of PAS positive cells per total epithelial cells. For
expression of IL-1R1, slides were pretreated with heat induced
epitope retrieval (HIER) before incubation over night at 4uC with
the primary goat anti-mouse IL-1R1 antibody (R&D Systems,
Minneapolis, MN, USA), followed by a secondary anti-goat
ImmPRESS antibody for 30 min at RT. Histological slides were
analyzed under the microscope (Olympus AX70), pictures were
taken with the Olympus DP70 camera using DPController
(Olympus) acquisition software.
Statistical analysis
Statistical analysis was performed using a Student’s t test, one-
way or two-way ANOVA with post test as appropriate. All
experiments were conducted independently at least twice P-values
of ,0.05 were considered significant and are shown as p,0.05 (*),
p,0.01 (**), or p,0.001 (***). Graph generation and statistical
analyses were performed using Prism version 4c software
(GraphPad, La Jolla, CA).
Supporting Information
Figure S1 THP-1 cells were transfected with shRNA for ASC,
NLRP3 or mock. After 3 hours of PMA stimulation cells were
activated with HES (5 mg/mL), P.HES (5 mg/mL) or HPL5
(5 mg/mL) for 18 hours. Cell supernatants were used for ELISA
detection of IL-1b.
(TIF)
Figure S2 Mice were administered 200 L3 Hp by oral gavage.
At 13 dpi single cell suspensions were made from (A) spleen, (B)
MLN and cells were restimulated with HES as described in the
Materials and Methods. The percentage of CD4+ T cells secreting
IL-17 in WT (C57BL/6) are shown. At 13 dpi absolute cell
numbers of CD4+ CD25+ foxp3+ T cells in (C) spleen and (D)
MLN are shown for WT (C57BL/6) vs. IL-1b2/2 mice. All results
are representative of at least 1 experiment (n = 6 per group) and
expressed as mean 6 SEM.
(TIF)
Figure S3 Mice were administered 200 L3 Hp by oral gavage.
WT (C57BL/6) additionally received 100 ml of PBS or PBS plus
50 mg/kg Anakinra via i.p. injection every day and intestinal
duodenum tissue cultures were analysed by ELISA for (A) IL-25
and (B) IL-33 cytokine levels at the indicated timepoints following
Hp infection. (C) Fecal egg counts were determined for WT (Balb/
c), IL-252/2, T1/ST22/2 and IL-17BR6T1ST22/2 mice
throughout the course of the experiment (data represents pooled
feces of 2–3 individual cages per strain, n = 2–5 mice per cage).
(TIF)
Figure S4 Mice were administered 200 L3 Hp by oral gavage.
(A) FACS analysis for absolute ILC2 numbers at 6 dpi with
expanded straining for the lineage negative panel to CD3, CD4,
CD11b, CD11c, CD19, Nk1.1, Ly6G and IgE. (B) FACS analysis
for absolute ILC2 numbers at 6 dpi gated on IL-13 cytokine
secreting ILC2s with the same lineage negative panel as in Fig.
S4A. Mice were administered 200 L3 Hp by oral gavage. WT
(C57BL/6) additionally received 100 ml of PBS or PBS plus
50 mg/kg Anakinra via i.p. injection every day and (C) numbers
of eosinophils present in the peritoneal wash at 6 dpi were
determined by differential cell counting of cytospins, (D) IL-5 and
(E) IL-13 cytoine levels in the peritoneal wash at the 6 dpi were
deterimend by ELISA.
(TIF)
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